Home
/
CV Sciences, Inc.
/
Financials
/
Quarterly
CV Sciences, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that CV Sciences, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2020
Mar 31, 2020
$8.27M
May 8, 2020
Q3
2019
Sep 30, 2019
$12.60M
Nov 6, 2019
Q2
2019
Jun 30, 2019
$16.85M
Aug 7, 2019
Q1
2020
Mar 31, 2019
$14.91M
May 8, 2020
Q3
2019
Sep 30, 2018
$13.60M
Nov 6, 2019
Q2
2019
Jun 30, 2018
$12.35M
Aug 7, 2019
Q1
2019
Mar 31, 2018
$8.07M
May 9, 2019
Q3
2018
Sep 30, 2017
$5.59M
Nov 7, 2018
Q2
2018
Jun 30, 2017
$4.08M
Aug 1, 2018
Q1
2018
Mar 31, 2017
$3.76M
May 14, 2018
Q3
2017
Sep 30, 2016
$2.94M
Nov 8, 2017
Q2
2017
Jun 30, 2016
$2.49M
Aug 11, 2017
Q1
2017
Mar 31, 2016
$2.42M
May 9, 2017
Q3
2015
Sep 30, 2015
$4.15M
Nov 16, 2015
Q2
2015
Jun 30, 2015
$2.41M
Aug 14, 2015
Q1
2016
Mar 31, 2015
$2.71M
May 16, 2016
Q3
2015
Sep 30, 2014
$1.86M
Nov 16, 2015
Q2
2015
Jun 30, 2014
$3.01M
Aug 14, 2015
Q1
2015
Mar 31, 2014
$2.63M
May 15, 2015
Q3
2014
Sep 30, 2013
$163.7K
Nov 14, 2014
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$3.26M
Nov 13, 2025
Q2
2025
Jun 30, 2025
$3.62M
Aug 13, 2025
Q1
2025
Mar 31, 2025
$3.61M
May 14, 2025
Q3
2025
Sep 30, 2024
$3.87M
Nov 13, 2025
Q2
2025
Jun 30, 2024
$3.95M
Aug 13, 2025
Q1
2025
Mar 31, 2024
$4.00M
May 14, 2025
Q3
2024
Sep 30, 2023
$4.09M
Nov 14, 2024
Q2
2024
Jun 30, 2023
$3.97M
Aug 13, 2024
Q1
2024
Mar 31, 2023
$4.15M
May 15, 2024
Q3
2023
Sep 30, 2022
$3.75M
Nov 14, 2023
Q2
2023
Jun 30, 2022
$4.14M
Aug 14, 2023
Q1
2023
Mar 31, 2022
$4.45M
May 15, 2023
Q3
2022
Sep 30, 2021
$5.11M
Nov 14, 2022
Q2
2022
Jun 30, 2021
$5.13M
Aug 15, 2022
Q1
2022
Mar 31, 2021
$4.84M
May 16, 2022
Q3
2021
Sep 30, 2020
$5.56M
Nov 15, 2021
Q2
2021
Jun 30, 2020
$5.40M
Aug 16, 2021
Q1
2021
Mar 31, 2020
$8.27M
May 13, 2021
Q3
2020
Sep 30, 2019
$12.60M
Nov 6, 2020
Q2
2020
Jun 30, 2019
$16.85M
Aug 7, 2020
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2016
Sep 30, 2016
$2.94M
Nov 1, 2016
Q2
2016
Jun 30, 2016
$2.49M
Aug 12, 2016
Q3
2016
Sep 30, 2015
$4.15M
Nov 1, 2016
Q2
2016
Jun 30, 2015
$2.41M
Aug 12, 2016
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($382.0K)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($261.0K)
Aug 13, 2025
Q3
2025
Jun 30, 2025
($261.0K)
Nov 13, 2025
Q3
2025
Mar 31, 2025
($109.0K)
Nov 13, 2025
Q2
2025
Mar 31, 2025
($109.0K)
Aug 13, 2025
Q1
2025
Mar 31, 2025
($109.0K)
May 14, 2025
Q3
2025
Sep 30, 2024
($456.0K)
Nov 13, 2025
Q3
2025
Jun 30, 2024
($584.0K)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($584.0K)
Aug 13, 2025
Q1
2025
Mar 31, 2024
($628.0K)
May 14, 2025
Q3
2025
Mar 31, 2024
($628.0K)
Nov 13, 2025
Q2
2025
Mar 31, 2024
($628.0K)
Aug 13, 2025
Q3
2024
Sep 30, 2023
($447.0K)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($1.29M)
Aug 13, 2024
Q3
2024
Jun 30, 2023
($1.29M)
Nov 14, 2024
Q3
2024
Mar 31, 2023
$5.71M
Nov 14, 2024
Q1
2024
Mar 31, 2023
$5.71M
May 15, 2024
Q2
2024
Mar 31, 2023
$5.71M
Aug 13, 2024
Q3
2023
Sep 30, 2022
($1.03M)
Nov 14, 2023
Q2
2023
Jun 30, 2022
($2.65M)
Aug 14, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($275.0K)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($131.0K)
Aug 13, 2025
Q1
2025
Mar 31, 2025
$11.0K
May 14, 2025
Q3
2025
Sep 30, 2024
($341.0K)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($583.0K)
Aug 13, 2025
Q1
2025
Mar 31, 2024
($620.0K)
May 14, 2025
Q3
2024
Sep 30, 2023
($437.0K)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($1.08M)
Aug 13, 2024
Q1
2024
Mar 31, 2023
$5.76M
May 15, 2024
Q3
2023
Sep 30, 2022
($892.0K)
Nov 14, 2023
Q2
2023
Jun 30, 2022
($2.32M)
Aug 14, 2023
Q1
2023
Mar 31, 2022
($1.52M)
May 15, 2023
Q3
2022
Sep 30, 2021
($2.98M)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($3.51M)
Aug 15, 2022
Q1
2022
Mar 31, 2021
($3.11M)
May 16, 2022
Q3
2021
Sep 30, 2020
($3.15M)
Nov 15, 2021
Q2
2021
Jun 30, 2020
($4.66M)
Aug 16, 2021
Q1
2021
Mar 31, 2020
($5.32M)
May 13, 2021
Q3
2020
Sep 30, 2019
($1.77M)
Nov 6, 2020
Q2
2020
Jun 30, 2019
$1.25M
Aug 7, 2020